Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
Horby PW. et al, (2023)
Reduced Left Atrial Rotational Flow Is Independently Associated With Embolic Brain Infarcts.
Journal article
Spartera M. et al, (2023), JACC Cardiovasc Imaging
Decoding the radiomic and proteomic phenotype of epicardial adipose tissue associated with adverse left atrial remodelling and post-operative atrial fibrillation in aortic stenosis.
Journal article
Mancio J. et al, (2022), Eur Heart J Cardiovasc Imaging, 23, 1248 - 1259
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Journal article
RECOVERY Collaborative Group None., (2022), Lancet, 400, 359 - 368
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2022), Lancet, 399, 665 - 676
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2022), Lancet, 399, 143 - 151
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Preprint
RECOVERY Collaborative Group None. et al, (2022)
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2022)
Higher dose corticosteroids in hospitalised COVID-19 patients with hypoxia but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2022)
REDUCED LEFT ATRIAL ROTATIONAL FLOW IS INDEPENDENTLY ASSOCIATED WITH THE RISK OF EMBOLIC BRAIN INFARCTS
Conference paper
Spartera M. et al, (2022), HEART, 108, A175 - A177
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), The Lancet. Respiratory medicine, 9, 1419 - 1426
The impact of atrial fibrillation and stroke risk factors on left atrial blood flow characteristics.
Journal article
Spartera M. et al, (2021), Eur Heart J Cardiovasc Imaging
The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19.
Journal article
Pessoa-Amorim G. and Mafham MM., (2021), Cardiovasc Res, 117, e110 - e113
Making trials part of good clinical care: lessons from the RECOVERY trial.
Journal article
Pessoa-Amorim G. et al, (2021), Future Healthc J, 8, e243 - e250
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2021)
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Preprint
RECOVERY Collaborative Group None. et al, (2021)
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Working paper
RECOVERY Collaborative Group None., (2021), Lancet, 397, 2049 - 2059
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Journal article
RECOVERY Collaborative Group None., (2021), Lancet, 397, 1637 - 1645
Left atrial 4D flow cardiovascular magnetic resonance: a reproducibility study in sinus rhythm and atrial fibrillation.
Journal article
Spartera M. et al, (2021), J Cardiovasc Magn Reson, 23
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Journal article
The RECOVERY Collaborative Group None. et al, (2021)